Top High Tech Stocks To Own For 2018

Piper’s Teen Survey Gives Possible Insight Into Future of Tech

Piper Jaffray’s out with its latest survey that it takes among 10,000 teenagers. The concept is to get a better feel for what young people like, ranging from favorite handbag brands to top restaurants and (importantly for Eye on Tech) their favorite social media platforms.

Perhaps with little surprise, Snap (Private:CHAT) garnered the top result, with 35% of the vote. coming in behind Snapchat is Facebook’s (NASDAQ:FB) Instagram, with just 24% of the votes. It wasn’t that long ago that Instagram was the top dog on the list and in the spring finally conceded its grip atop the Iron Throne.

Engagement at Instagram is up – which is good for Facebook – but engagement for its own platform is down among teens. Perhaps with Instagram copying some of Snapchat’s biggest features and the subsequent growth that has followed will help buoy the social media platform.

But the latest results could draw at least a little bit of concern considering that Snapchat continues to gobble up market share as the most preferred platform.

Top High Tech Stocks To Own For 2018: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Chris Lange]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI).

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at

    About Syndax Pharmaceuticals

  • [By Lisa Levin]

    Shares of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) got a boost, shooting up 32 percent to $12.40 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients with disease progression on or after PD-1 therapies.

Top High Tech Stocks To Own For 2018: Snyder's-Lance, Inc.(LNCE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Snyder’s-Lance Inc (NASDAQ: LNCE) is estimated to report its quarterly earnings at $0.23 per share on revenue of $470.33 million.

    Examworks Group, Inc. (NYSE: EXAM) is projected to post its quarterly earnings at $0.08 per share on revenue of $217.47 million.

Top High Tech Stocks To Own For 2018: (VIAB)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    This morning, President Trump suggested that the United States is considering strong military action in response to recent chemical attacks carried out on civilians by the Syrian government. The president promised to send “nice and new and ‘smart'” missiles to Syria and accused the Russian government of partnering with a “Gas Killing Animal who kills his people and enjoys it!” The president’s remarks are a significant departure from comments made last week, which suggested that the United States would be pulling out of Syria in the coming months. Trump’s threat of war over a recent chemical attack in Syria drove crude oil and gold prices higher. Geopolitical worries often offer a boost to commodity prices due to concerns about supply. Trump’s threat comes at a time that markets are already concerned about a significant military conflict in the Middle East between Saudi Arabia and Iran. WTI crude prices added 0.9% to hit $66.10 per barrel. Brent crude pushed to $71.10 per barrel. Gold price topped $1,350 per ounce and are poised for bigger gains. According to Axios, U.S. Speaker of the House Paul Ryan (R-WI) has privately told friends that he will not seek reelection in the fall. The news comes at a perilous time for Republicans, who are expected to lose the House of Representatives and potentially the Senate. Axios was the first to report the news. The story is also notable because Ryan recently achieved his long-time goal of passing tax reform in late 2017.
    Four Stocks to Watch Today: FB, FOXA, CBS
    Shares of Twenty-First Century Fox Inc.(NYSE: FOXA) fell in pre-market hours on news that investigators from the European Commission raided the firm’s London office yesterday. Reports indicate that investigators are trying to keep their goals confidential. However, there has been a lot of scrutiny over Rupert Murdoch’s goal to purchase rival Sky in recent months. British authorities have argued that this deal would not be in the public’s best interest. Accor

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.


    Viacom (VIAB) CEO Bob Bakish wants to make a clean break with a sluggish past.

    In a mover that follows a reorganization of Viacom’s cable TV network group, Bakish on Wednesday announced that Brad Grey will leave Paramount Pictures after 12 years atop the Hollywood studio.

  • [By Douglas A. McIntyre]

    CBS Corp. (NYSE: CBS) may make a low-ball bid to buy Viacom Inc. (NASDAQ: VIAB). According to Bloomberg:

    CBS Corp. will offer less than the current market value of Viacom Inc. in its opening bid for the owner of MTV and Nickelodeon, according to a person with knowledge of the matter, showing how far apart the companies are as they explore recombining.

  • [By Lisa Levin]

    U.S. stock futures traded higher in early pre-market trade, ahead of earnings from Wal-Mart Stores Inc (NYSE: WMT), Viacom, Inc. (NASDAQ: VIAB) and Best Buy Co Inc (NYSE: BBY). Data on initial jobless claims for the latest week, the Philly Fed manufacturing index for November and data on import prices for October will be released at 8:30 a.m. ET. Data on industrial production for October will be released at 9:15 a.m. ET, while the housing market index for November is schedule for release at 10:00 a.m. ET. Cleveland Federal Reserve Bank President Loretta Mester is set to speak in Washington at 9:10 a.m. ET, while Dallas Federal Reserve Bank President Robert Kaplan will speak in Houston at 1:10 p.m. ET. Federal Reserve Governor Lael Brainard is set to speak in Ann Arbor, Michigan at 3:45 p.m. ET.

Top High Tech Stocks To Own For 2018: Halyard Health, Inc.(HYH)

Advisors’ Opinion:

  • [By Nelson Hem]

    See what Barron’s feels are the prospects for Ingersoll-Rand PLC (NYSE: IR) despite the woes in energy, Michael Kors Holdings Ltd (NYSE: KORS) with its new products and international expansion, the Valvoline spinoff from Ashland Inc (NYSE: ASH), as well as Halyard Health Inc (NYSE: HYH) as it pursues acquisitions and expands its product lineup.

  • [By Nelson Hem]

    Medical products maker Halyard Health Inc (NYSE: HYH) stumbled after its spinoff from paper products giant Kimberly Clark Corp (NYSE: KMB), according to “Halyard Health Shares Look Poised to Double” by David Englander. See why Barron’s thinks its shares could double as this Georgia-based company pursues acquisitions and expands its product lineup.

Leave a Reply

Your email address will not be published. Required fields are marked *